How aging, Alzheimer's, and PTSD change fear and the amygdala

The Impact of Normative Aging and Alzheimers Disease on Fear based Disorders and Amygdala Dysfunction

NIH-funded research University of Alabama at Birmingham · NIH-11143192

This project looks at whether ketogenic diets or ketone supplements can reduce persistent fear memories and amygdala inflammation in older people with or at risk for Alzheimer's, including those with PTSD.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham NIH-funded
Lab location1 site (Birmingham, United States)
Project IDNIH-11143192 on NIH RePORTER

What this research studies

Researchers will study how normal aging, Alzheimer's disease, and PTSD affect fear memories and function of the basolateral amygdala (BLA). They will use animal models of Alzheimer's and PTSD and examine brain inflammation, amygdala activity, and behavior related to fear memory and extinction. The team will test whether ketogenic diets or ketone esters can reduce amygdala hyperactivity and neuroinflammation that worsen fear-based symptoms and cognitive decline. Results are intended to point toward metabolic or diet-based strategies that could later be tested in people.

Who could benefit from this research

Good fit: Ideal candidates would be older adults with a history of PTSD, people living with Alzheimer's disease or mild cognitive impairment, or those experiencing age-related memory decline.

Not a fit: People without fear-based disorders, younger adults without age-related memory changes, or those whose symptoms arise from non-inflammatory causes may be less likely to benefit.

Why it matters

Potential benefit: If successful, this work could point to diet-based or metabolic therapies that reduce persistent fear memories and slow cognitive decline in people with PTSD and Alzheimer's disease.

How similar studies have performed: Previous animal studies and some small human trials suggest ketogenic diets or ketone supplements can reduce brain inflammation and improve cognition, but applying this approach to amygdala dysfunction in aging and PTSD is relatively new.

Where this research is happening

Birmingham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.